Occudo Quantitative Strategies LP Dynavax Technologies Corp Transaction History

Occudo Quantitative Strategies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	BUY	$9.85 - $13.17 $143,012 - $191,215	14,519 New	14,519 $187,000
Q2 2022 Aug 15, 2022	SELL	$7.45 - $12.83 $522,267 - $899,421	-70,103 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$9.75 - $14.44 $320,482 - $474,642	32,870 Added 88.28%	70,103 $760,000
Q4 2021 Feb 14, 2022	BUY	$13.17 - $20.94 $490,358 - $779,659	37,233 New	37,233 $524,000
Q1 2021 May 14, 2021	SELL	$4.57 - $11.18 $60,191 - $147,251	-13,171 Closed	0 $0
Q4 2020 Feb 16, 2021	BUY	$3.73 - $5.6 $49,127 - $73,757	13,171 New	13,171 $59,000

275

130M

451K

203K

Ticker DVAX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 126,474,000
Market Cap $1.63B
Description
Dynavax Technologies Corporation, a biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. The company markets HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in age 18 years and older in the United States and Europe. It also manufa...

Get notified when there are updates to the investment portfolio of Occudo Quantitative Strategies LP, based on Form 13F filings with the SEC.

Stay updated on Occudo Quantitative Strategies LP with notifications on news.